At ViewRay, we are dedicated to giving clinicians new and better ways to treat cancer with radiation therapy. We are passionate about cancer research and are partnering with physicians and institutions worldwide to advance patient treatment.
Designed specifically for radiation oncology, MRIdian clinical use spans over five years of treating approximately 6,500* patients with more than 10,000 adaptive treatments on nearly 50 ICD-10 codes. Search over 95 peer-reviewed articles and more than 100 abstracts for additional scientific information.
*Hospital reported and ViewRay internal data on file (as of 22 November 2019)
Our collaborative research program involves partnering with physicians and institutions to transform cancer treatment.
The MRIdian Linac System, with magnetic resonance imaging capabilities, is intended to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated. Medical information services provides support for medical, scientific, and technical information in response to inquiries regarding the use of ViewRay products. Contact our Medical Affairs team at MedicalAffairs@viewray.com for more information.
Sign up for notifications and details.